Genotoxicity of 3′-azido-3′-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT

This publication has 19 references indexed in Scilit:

• Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke
  Nature Medicine, 1998
• Transplacental Effects of 3'-Azido-2',3'-Dideoxythymidine (AZT): Tumorigenicity in Mice and Genotoxicity in Mice and Monkeys
  JNCI Journal of the National Cancer Institute, 1997
• Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
  New England Journal of Medicine, 1996
• Nonclinical Toxicology Studies with Zidovudine: Genetic Toxicity Tests and Carcinogenicity Bioassays in Mice and Rats
  Fundamental and Applied Toxicology, 1996
• Clinical Pharmacokinetics of Zidovudine
  Clinical Pharmacokinetics, 1996
• 3′-azido-3′-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8
  Biochemical Pharmacology, 1994
• Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families
  Genomics, 1990
• Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification
  Nucleic Acids Research, 1988
• Mutation assay at the thymidine kinase locus in diploid human lymphoblasts
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982